loading

Finanzdaten der Solid Biosciences Inc-Aktie (SLDB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
15.27%
48.06
41.69 40.05 39.90 35.18
Depreciation and Amortization
2.59%
0.376
0.386 0.407 - -
Operating Income/Loss
15.27%
-48.06
-41.69 -40.05 -39.90 -35.18
Nonoperating Income/Loss
3.12%
2.282
2.213 0.77 -2.701 2.457
Income/Loss From Continuing Operations Before Tax
15.95%
-45.78
-39.48 -39.28 -42.60 -32.73
Income/Loss From Continuing Operations After Tax
15.95%
-45.78
-39.48 -39.28 -42.60 -32.73
Net Income/Loss
15.95%
-45.78
-39.48 -39.28 -42.60 -32.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.29%
94.42
94.14 66.34 0.6344 41.44
Diluted Average Shares
0.29%
94.42
94.14 66.34 0.6344 41.44
Basic Earnings Per Share
14.29%
-0.48
-0.42 -0.59 -1.02 -0.79
Diluted Earnings Per Share
14.29%
-0.48
-0.42 -0.42 -1.02 -0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):